USE OF AN ANTI-TAU PS422 ANTIBODY FOR THE TREATMENT OF BRAIN DISEASES
摘要
<p>Patent No. 596187 Disclosed is the use of an antibody binding to Tau, phosphorylated at serine 422 (Tau pS422), characterized in specifically binding to phosphorylated Tau and to Tau pS422, but not binding to Tau and to phosphorylated MCAK fragment, for the manufacture of a medicament for the treatment of a Tautopathy.</p>
